These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32469415)

  • 1. Antenatal Corticosteroids and Magnesium Sulfate for Improved Preterm Neonatal Outcomes: A Review of Guidelines.
    Tsakiridis I; Mamopoulos A; Athanasiadis A; Dagklis T
    Obstet Gynecol Surv; 2020 May; 75(5):298-307. PubMed ID: 32469415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes.
    Skoll A; Boutin A; Bujold E; Burrows J; Crane J; Geary M; Jain V; Lacaze-Masmonteil T; Liauw J; Mundle W; Murphy K; Wong S; Joseph KS
    J Obstet Gynaecol Can; 2018 Sep; 40(9):1219-1239. PubMed ID: 30268316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preterm labor: approach to decreasing complications of prematurity.
    Locatelli A; Consonni S; Ghidini A
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):255-74. PubMed ID: 26002165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010-2013.
    Siwicki K; Bain E; Bubner T; Ashwood P; Middleton P; Crowther CA
    Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):233-8. PubMed ID: 26084194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals.
    Bousleiman SZ; Rice MM; Moss J; Todd A; Rincon M; Mallett G; Milluzzi C; Allard D; Dorman K; Ortiz F; Johnson F; Reed P; Tolivaisa S;
    Am J Obstet Gynecol; 2015 Sep; 213(3):398.e1-11. PubMed ID: 25957021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preterm Labor: A Comprehensive Review of Guidelines on Diagnosis, Management, Prediction and Prevention.
    Giouleka S; Tsakiridis I; Kostakis N; Koutsouki G; Kalogiannidis I; Mamopoulos A; Athanasiadis A; Dagklis T
    Obstet Gynecol Surv; 2022 May; 77(5):302-317. PubMed ID: 35522432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey on use of antenatal magnesium sulphate for fetal neuroprotection prior to preterm birth in Australia and New Zealand - Ongoing barriers and enablers.
    Gatman K; May R; Crowther C
    Aust N Z J Obstet Gynaecol; 2020 Feb; 60(1):44-48. PubMed ID: 31119725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Committee Opinion No 652: Magnesium Sulfate Use in Obstetrics.
    Obstet Gynecol; 2016 Jan; 127(1):e52-e53. PubMed ID: 26695587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of preterm birth complications by antenatal corticosteroid administration].
    Schmitz T
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1399-1417. PubMed ID: 27776846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Committee Opinion No. 652 Summary: Magnesium Sulfate Use in Obstetrics.
    Obstet Gynecol; 2016 Jan; 127(1):195. PubMed ID: 26695582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes): Guidelines for clinical practice - Text of the Guidelines (short text)].
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1446-1456. PubMed ID: 27836377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health.
    Vogel JP; Souza JP; Gülmezoglu AM; Mori R; Lumbiganon P; Qureshi Z; Carroli G; Laopaiboon M; Fawole B; Ganchimeg T; Zhang J; Torloni MR; Bohren M; Temmerman M;
    Lancet; 2014 Nov; 384(9957):1869-1877. PubMed ID: 25128271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes.
    Battarbee AN; Ros ST; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Andrews W; Saade G; Sadovsky Y; Reddy UM; Varner MW; Manuck TA;
    Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100077. PubMed ID: 32905377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal corticosteroids in the management of preterm birth: are we back where we started?
    Bonanno C; Wapner RJ
    Obstet Gynecol Clin North Am; 2012 Mar; 39(1):47-63. PubMed ID: 22370107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of clinical chorioamnionitis: an evidence-based approach.
    Conde-Agudelo A; Romero R; Jung EJ; Garcia Sánchez ÁJ
    Am J Obstet Gynecol; 2020 Dec; 223(6):848-869. PubMed ID: 33007269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now?
    Kamath-Rayne BD; Rozance PJ; Goldenberg RL; Jobe AH
    Am J Obstet Gynecol; 2016 Oct; 215(4):423-30. PubMed ID: 27342043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal Growth Restriction: A Comprehensive Review of Major Guidelines.
    Giouleka S; Tsakiridis I; Mamopoulos A; Kalogiannidis I; Athanasiadis A; Dagklis T
    Obstet Gynecol Surv; 2023 Nov; 78(11):690-708. PubMed ID: 38134339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational Hypertension and Preeclampsia: An Overview of National and International Guidelines.
    Tsakiridis I; Giouleka S; Arvanitaki A; Giannakoulas G; Papazisis G; Mamopoulos A; Athanasiadis A; Dagklis T
    Obstet Gynecol Surv; 2021 Oct; 76(10):613-633. PubMed ID: 34724074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.